Dominantly acting, allelic mutations of the fibroblast growth factor receptor 2 (FGFR2) gene have been described in five craniosynostosis syndromes. In Apert syndrome, characterised by syndactyly of the hands and feet, recurrent mutations of a serine-proline dipeptide (either Ser252Trp or Pro253Arg) in the linker between the IgII and IgIII extracellular immunoglobulin-like domains, have been documented in more than 160 unrelated individuals. We have identified three novel mutations of this dipeptide, associated with distinct phenotypes. A C!T mutation that predicts a Ser252Leu substitution, ascertained in a boy with mild Crouzon syndrome (craniosynostosis with normal limbs) is also present in three clinically normal members of his family. A CG!TT mutation that predicts a Ser252Phe substitution results in a phenotype consistent with Apert syndrome. Finally, a CGC!TCT mutation that predicts a double amino acid substitution (Ser252Phe and Pro253Ser) causes a Pfeiffer syndrome variant with mild craniosynostosis, broad thumbs and big toes, fixed extension of several digits, and only minimal cutaneous syndactyly. The observation that the Ser252Phe mutation causes Apert syndrome, whereas the other single or double substitutions are associated with milder or normal phenotypes, highlights the exquisitely specific molecular pathogenesis of the limb and craniofacial abnormalities associated with Apert syndrome. Ser252Phe is the first noncanonical mutation to be identified in this disorder, its rarity being explained by the requirement for two residues of the serine codon to be mutated. The description of independent, complex nucleotide substitutions involving identical nucleotides is unprecedented, and we speculate that this may result from functional selection of FGFR mutations in sperm.
INTRODUCTION
There has been considerable progress in understanding the genetic basis of craniosynostosis, the premature closure of the sutures of the skull. Mutations in fibroblast growth factor receptors (FGFRs) 1-3 have been identified in Crouzon, Apert, Pfeiffer, Jackson-Weiss and Beare-Stevenson syndromes, as well as in non-syndromic craniosynostosis (reviewed in refs [1] [2] [3] 4, 5) . Distinct mutations of FGFR3 have also been identified in hypochondroplasia, achondroplasia and thanatophoric dysplasia, disorders of long bone growth (6 and references therein). All FGFR mutations identified to date are dominantly acting and many are highly localised; in the case of FGFR2 and FGFR3, different syndromes result from allelic mutations of the same gene. This suggests that the mutations act by a variety of distinct gain-of-function mechanisms; this is supported for certain mutations by recent functional studies (7) (8) (9) (10) (11) .
A class of FGFR mutations whose mechanism is not understood affects the putative linker between the second (IgII) and third (IgIII) extracellular immunoglobulin-like domains of FGFRs 1, 2 and 3 [mutations of the linker to cysteine, which occur in FGFR3, are likely to act by a different mechanism (9, 12) and are not considered further here]. This linker is contained within a sequence of 16 amino acids identical between all four human FGFRs (13) and mutations of this region in FGFRs 1, 2 and 3 give rise to distinct syndromes. In FGFR1, a Pro252Arg mutation present in nine families with Pfeiffer syndrome (craniosynostosis with broad big toes and thumbs) is the only constitutional *To whom correspondence should be addressed . The bottom panel shows mutations of the serine-proline dipeptide that have been described previously (left) and in this report (right). Abbreviations: L, leader sequence; IgI, IgII, IgIII, immunoglobulin-like domains I, II and III respectively; A, acidic box; C, CAM homology domain; TM, transmembrane region; TK1 and TK2, tyrosine kinase domains. Updated from (3) with additional mutations (4, 17) . mutation of this gene described to date (14) (15) (16) . In FGFR2 (Fig. 1) , mutations of adjacent amino acids (Ser252Trp and Pro253Arg) have been identified in 165 of 166 unrelated patients with Apert syndrome (craniosynostosis with bony syndactyly of the hands and feet) (16, (18) (19) (20) . In FGFR3, a Pro250Arg mutation was recently described in 10 families with non-syndromic craniosynostosis (5). It is remarkable that mutations of the homologous proline to arginine have been observed in FGFRs 1, 2 and 3, yet no other substitution of this proline has previously been described. In the case of FGFR2, the Apert syndrome phenotypes attributable to the Ser!Trp and Pro!Arg substitutions, although not identical, are very similar (19, 21) , suggesting that these two mutations have similar functional effects on the FGFR molecule. Given evidence for the involvement of the IgII and IgIII domains in fibroblast growth factor (FGF) binding (22) (23) (24) it has been suggested that bulky substitutions of the linker might alter the relative orientation of the domains and hence either accentuate the binding of a natural ligand, or create a novel ligand binding affinity (12) . Such a mechanism, if confirmed experimentally, would provide an important paradigm for understanding the mode of action of this class of dominant mutations.
To explore the biology of the IgII-IgIII linker region of FGFR2 in detail, we have searched for rare mutations of this region in patients with craniosynostosis in whom the more common FGFR2 mutations had been excluded. Three previously undescribed mutations of the serine-proline dipeptide have been identified: the resulting phenotypes provide further insight into the structure-function relationships of mutations in the linker region. We discuss these findings with particular reference to the codon limitations to mutational spectra and the possibility of positive selection for mutation.
RESULTS

Patients
Case JM and his family are shown in Figure 2A . His parents and all three siblings are clinically normal. JM was born at term following a normal pregnancy and weighed 2900 g (-1.2 SD), with a birth length of 52 cm (+0.5 SD). No abnormalities were noted until the age of 4 years, when midface hypoplasia became apparent. This worsened progressively, and prior to surgery he was reported to have ocular proptosis, a flat nasal bridge and severe class III malocclusion. In addition he had a bifid uvula, pectus carinatum and myopia; the hands and feet appeared normal. A CT head scan at age 7.5 years revealed synostoses of the lambdoid, posterior portion of the sagittal and lateral portion of the coronal sutures. A diagnosis of Crouzon syndrome was made and aged 7 years he underwent a LeFort III midface advancement with frontocranial remodelling.
Case SY is shown in Figure 2B . Her parents and two older siblings are clinically normal. She was born at 38 weeks gestation and weighed 2927 g (50th centile). Brachycephaly, midfacial flattening and syndactyly of the hands and feet were apparent, suggesting a diagnosis of Apert syndrome. CT head scanning showed bilateral coronal synostosis and bilateral choanal stenosis. X-rays of the hands showed bilateral fusion of the proximal and middle phalanges of digits 2-4 and on the right, possible fusion of the 4th and 5th metacarpal, and 3rd and 4th proximal phalanx. According to a clinical classification (21) the morphological scores for her hands and feet are both 1 (the mildest grade), the radiological score for her hands is 1 on the left and 2 on the right.
The clinical features of case GR are shown in Figure 2C . He is the only affected member in his family. He presented aged 16 months with fixed extension bilaterally at the proximal interphalangeal (p.i.p.) joints of the index fingers, and restricted p.i.p. joint flexion of the right middle finger. Hand X-rays showed delayed epiphyseal ossification of the middle phalanges, but no reported ankylosis. Multiple operations to mobilise the fingers were required during childhood. At 12 years, mild cutaneous syndactyly of the middle three fingers bilaterally, and of the left second and third toes was recorded. An unusual craniofacial appearance and broad thumbs and big toes were noted, leading to a diagnosis of a variant of Pfeiffer syndrome. The old reports of plain skull radiographs (which have been lost) are conflicting: one at age 7 
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years was said to be normal whilst another at 12 years showed 'changes compatible with Apert syndrome'. His early development and schooling was normal. Now aged 32 years, he has never had craniofacial surgery. His facial appearance is unusual with macrocephaly (head circumference 60.3 cm, +2.0 SD; height 173 cm), prominent eyes, hypertelorism, long pointed ears and a high-arched, non-cleft palate. In the hands he has broad thumbs, brachydactyly of all digits with fixed extension of the metacarpo-phalangeal joints of digits 1 and 2, the p.i.p. joint of digit 2 and the distal interphalangeal joint of digits 2 and 5. There is minimal webbing between the digits (Fig. 2C) . In the feet he has large but non-deviated halluces, restricted flexion of all toes, and partial 2/3 cutaneous syndactyly. Radiographs of the hands showed short proximal and middle phalanges, digit 5 having only two phalanges. In the feet, the halluces are broad and the bases of the 1st metatarsals each have exostosis-like partial duplications (Fig. 2C) .
Identification of nucleotide substitutions in IgII-IgIII linker of FGFR2
DNA sequence analyses of genomic PCR product from patient JM, and cloned mutant alleles from patients SY and GR are shown in Figure 3 , with the wild-type sequence for comparison. These novel mutations are summarised and compared with the previously described Apert mutations in Figure 1 . Patient JM has a single nucleotide substitution (C!T) of residue 934 according to the cDNA numbering of Dionne et al. (25) , which alters the TCG (Ser252) codon to TTG (Leu). This abolishes MboI and BsiEI sites, which we used to screen other family members for the mutation. This showed that the mother and both sisters of JM carry the same C934T mutation (Fig. 4A ), yet all three individuals are clinically normal. The mother's parents were unavailable for analysis. To investigate the reasons for the discrepancy in phenotype between the proband and other family members, we searched DNA from JM for additional mutations of FGFR2 and FGFR3 (see Materials and Methods), but no other sequence abnormality was found.
Initial double stranded sequencing in the other two patients suggested that contiguous nucleotides were mutated. To confirm their identity and phase in cis, we analysed cloned mutant alleles. Patient SY has a double nucleotide substitution (CG!TT) of residues 934 and 935, which alters the Ser252 codon to TTT (Phe). Patient GR has a triple nucleotide substitution (CGC!TCT) of residues 934-936, which alters both the Ser252 codon to TTC (Phe), and the downstream CCT (Pro253) codon to TCT (Ser). Note that the C934T substitution is present in all three patients.
Given their complex nature, we considered it important to confirm the identity of the SY and GR mutations in genomic DNA. Both are predicted to abolish MboI and BglI sites and the GR mutation creates a HinfI site; all these changes were present (data not shown). As these restriction site changes are not fully diagnostic, we hybridised 32 P-labelled oligonucleotides corresponding to the mutant sequences to blots of cloned and PCR amplified fragments (Fig. 4B) . The results confirm the nature of the mutations and in both cases, show that they arose de novo and that no other family members are affected. We determined the parental origin of the mutations by a combination of ARMS and linkage analysis (see Materials and Methods). Both the SY and the GR mutations were paternal in origin (data not shown).
In fibroblast cultures from patient GR we checked that RNA splicing was unaffected and that there was comparable expression of the normal and mutant alleles (data not shown). This strengthens the evidence that the variant Pfeiffer phenotype in this patient results from the combined Ser252Phe and Pro253Ser substitutions, rather than a more gross disruption of the FGFR2 message.
Screening for Ser252 polymorphism
To determine whether the Ser252Leu mutation occurs at significant frequency in the normal population, we screened >400 unrelated individuals for normal digestion at a BsiEI site that includes the Ser252 codon: this site is abolished by all three newly identified mutations and will detect all other substitutions of the serine codon except Ser!Pro, as well as the silent substitution TCG!TCA (see below). All samples showed a normal pattern of digestion, indicating that natural polymorphism of this residue is very rare.
DISCUSSION
We have identified three novel mutations of the IgII-IgIII linker of FGFR2 associated with a wide range of phenotypes, ranging from normal (3/4 individuals with the Ser252Leu mutation) to fairly typical Apert syndrome (Ser252Phe mutation). Together with the previously described Apert mutations, this series allows quite a detailed appraisal of the structural and functional effects of these linker region mutations. The very narrow mutational spectrum and high mutation rate in Apert syndrome (20) lends particular biological interest to the problem, with implications for understanding limb development and mutation mechanisms.
The phenotypic effects of the five different mutations in the IgII-IgIII linker of FGFR2 are summarised in Figure 1 . The Ser252Phe substitution (case SY) is the first non-canonical mutation to be described in Apert syndrome. Functionally, this suggests that substitution of the Ser252 residue to either Trp or Phe (both of which have bulky, non-polar side chains; ref. 26 ) has similar consequences, the relative rarity of the mutation to phenylalanine being readily explained by the requirement for two residues of the serine codon to be mutated simultaneously. Given the difference in the codon used to encode the homologous serine between FGFR2 (TCG) and FGFR1 and 3 (TCC), a corollary is that whereas Ser!Trp mutations would only be encountered in FGFR2, Ser!Phe mutations could occur by substitution of a single nucleotide (TCC!TTC) in FGFR1 and 3. We suggest that the latter mutations should be specifically looked for in craniosynostosis patients with unknown molecular pathology.
The absence of the Apert phenotype when a different single nucleotide substitution (Ser252Leu; family JM) is present, reinforces the point that the specificity of Apert syndrome depends not only on the position of mutations within the IgII-IgIII linker but also their molecular identity. It seems unlikely that any of the other possible single nucleotide substitutions that mutate the Ser252 codon (yielding Pro, Thr, Ala and 
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Stop) would cause Apert syndrome. Moreover, abolition of the Apert phenotype when the Ser252Phe substitution is accompanied by an adjacent Pro253Ser change (case GR) demonstrates that the conformation of FGFR2 giving rise to syndactyly depends not only on particular mutant amino acids, but also on there being specific amino acids at neighbouring sites. The amino acid identity of all four human FGFRs in this region (13) , the absence of detectable polymorphism of Ser252 in FGFR2 (this paper), and the description of mutations of proline to arginine (but no other amino acid) in homologous IgII-IgIII linker regions of FGFRs 1, 2 and 3 (5, 14, 18) all support the proposition of exquisite specificity. Although some variability in phenotype attributable to particular mutations elsewhere in FGFR2 has been described (27, 28) and is evident with the Ser252Leu mutation, the extremes of phenotype (from clinically normal to Apert syndrome) identified here are much wider. These newly identified mutations will provide specific, testable hypotheses for studies of their effects on molecular structure and mechanism of action.
The identification of the C934T (Ser252Leu) mutation is of particular interest because its occurrence was predicted when the molecular basis of Apert syndrome was originally reported (18) . The argument runs as follows. As the Ser252 codon of FGFR2 is encoded by TCG, it is expected to be hypermutable, either to TTG (the leucine mutation) or TCA (a silent change), provided that the cytosine residues in the CpG dinucleotide are methylated (29, 30) . We have confirmed this latter point in blood and sperm by comparison of MboI and Sau3AI digest patterns (31) and bisulphite sequencing (32) (D.M.M., A.O.M.W., unpublished data). By analogy with other genetic disorders (29) , the C934T and G935A transitions are predicted to be about eight times as frequent as the C934G transversion that causes the Ser252Trp Apert mutation, the germline mutation rate for which has been estimated as 5 × 10 -6 (20) . This would give a theoretical germline mutation rate of 4 × 10 -5 for these two transitions. Given that G935A is selectively neutral, and (from the evidence of this paper) C934T is likely to be nearly so, one or both of these changes should have reached measurable frequency during human evolution. Our failure to identify either change in >800 normal chromosomes suggests that the germline mutation rates at these positions are actually substantially lower.
The observation of two independent complex germline substitutions occurring at an identical site (cases SY, GR) is unprecedented. A search of published databases of constitutional mutations in a wide variety of genes (33) revealed less than 10 examples of double nucleotide substitution and we are only aware of one case of triple substitution (34) . Double nucleotide substitutions are somewhat more frequent in surveys of tumour material for acquired somatic mutations, accounting for 13/1373 substitutions in a TP53 database (35) and 5/146 in a CDKN2A database (36) . Excluding CC!TT changes, which occur by a specific photochemical mechanism (37), double substitutions account for ∼0.7% of the nucleotide substitutions observed for these genes in tumour tissue. Their higher frequency in tumours relative to germline mutations may be related to the high selective pressures that occur during tumorigenesis, although reduced fidelity of transcription may also contribute. The question arises whether an analogous selection process could be involved in the occurrence of the two complex germline substitutions at the same site that we have observed in FGFR2.
We have previously demonstrated the exclusive paternal origin of mutation in Apert syndrome in 57/57 cases, and suggested that the high apparent rates for several FGFR mutations could arise by a selective advantage conferred to the mutated male germ cell (20) . Consistent with this, there is evidence that the FGF/FGFR signalling pathway plays an important role in the initiation and maintenance of spermatogenesis (38) . Our new observations that (i) the C934T substitution is associated with a normal or mild phenotype (family JM), (ii) when accompanied by additional substitutions, the phenotype is more severe (cases SY and GR) and (iii) these latter mutations are paternally derived lead us to a possible scenario for the origin of these mutations. We speculate that the C934T mutation occurs rarely and conveys little or no advantage to the male germ cell, but is selected when a second mutation generates a functionally activated form of FGFR2 (Fig.  5) . This might occur either by miscopying of adjacent nucleotide(s), or in the case of patient GR, by miscorrection following transient mispairing to a homologous region within the upstream intron (30) . The two canonical Apert mutations might have a similar or greater selective advantage in male gametogenesis. We are currently attempting to detect these mutations directly in human sperm to evaluate this hypothesis.
MATERIALS AND METHODS
Characterisation of FGFR2 mutations
Previously unpublished primers used in the analysis [with co-ordinates relative to first nucleotide (=0) of the IIIa exon of FGFR2] were 6/7BF (5′-TGGCATGAGGTCACTGACAG-3′; -98/-79), MR2E7R (5′-CTGTAAACCTTGCAGACAAAC-3′; +96/+76) and 5/6R2 (5′-CCAACAGGAAATCAAAGAACC-3′; +273/+253). The 5′ portion of exon IIIa was amplified using the 6/7AF-5S primer pair (21) and single strand conformational polymorphism (SSCP) analysis was performed as previously described (18) . Fragments showing abnormal migration were directly sequenced with primer MR2E7R after selecting single stranded product using Dynabeads M-280 Streptavidin by incorporating a 5′ biotin label into the 6/7AF primer. Mutant alleles were isolated by cloning products from the 6/7BF-5/6R2 amplification into pT7Blue(R) T Vector (Novagen) and were sequenced with [ 32 P]dCTP-labelled 5S primer and the Thermo Sequenase cycle sequencing kit (Amersham). In patient JM, the IIIc and remainder of the IIIa exon of FGFR2, and the Ala391 residue of FGFR3, were confirmed to have normal sequence (16, 39) . Other members of the JM family were screened for the Ser252Leu mutation by abolition of MboI and BsiEI sites. Polymorphism at the Ser252 residue was screened for by digestion of the 6/7AF-5S PCR product from normal individuals with BsiEI.
Oligonucleotide hybridisation
To confirm that artefactual mutations had not been introduced into mutant recombinants from SY and GR during cloning, normal and mutant clones and directly amplified PCR products from the patient and other relatives were electrophoresed on a 2% agarose gel and blotted onto Hybond-N+ membrane (Amersham). Oligonucleotides were labelled with [ 32 P]dCTP and terminal transferase (Boehringer Mannheim), hybridised overnight in 7% polyethylene glycol/10% SDS at 42_C, and washed in 2× SSC/0.1% SDS at 60_C for 30 min. For patient SY, the mutant oligonucleotide 5′-GATTTCCTCACCGGCCCA-3′ was used; for patient GR, the mutant oligonucleotide was 5′-GATTCTCTCACCGGCCCA-3′ (mismatches from the normal sequence are underlined).
Parental origin of mutations
The parental origin of the mutation in case SY was determined by amplification refractory mutation system (ARMS) analysis as previously described (20) . The family was informative for the G/A polymorphism (father AA, mother GG, child AG). After selective amplification of the child's A allele (inherited from the father), incubation with BsiEI and BglI indicated that the wild-type restriction sites were absent. This shows that the mutant allele was paternally derived. Case GR was not informative for the ARMS polymorphisms, but we used his unaffected son to determine the phase of the mutation with the microsatellites D10S190, D10S209 and D10S587 (Research Genetics), which flank and are closely linked to FGFR2. The son had inherited GR's maternal allele, hence GR's mutation is also paternally derived.
RNA analysis
RNA was extracted (40) from fibroblast cultures established from case GR. Reverse transcriptase PCR (RT-PCR) was performed using the primer pair 3F-7R for 35 cycles (18) . The presence of the normally spliced, mutant allele in the product was confirmed by digestion with MboI and HinfI.
